NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Old Version 13

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

compared with

New Version Current

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Updated to reflect UI changes apparently released with STRAP-130.

...

Data ElementDescription
NCI ID

The

Include Page
Trial Attribute NCI ID - Include v4.4
Trial Attribute NCI ID - Include v4.4

DCP IDIdentifier assigned to this trial by the CTRP.DCP IDIdentifier assigned to this trial by the DCP (Division of Cancer Prevention).

The

Include Page
Trial Attribute DCP ID - Include v4.4
Trial Attribute DCP ID - Include v4.4

For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers.

CTEP ID

The

Include Page
Trial Attribute CTEP ID

Identifier assigned to this trial by the CTEP (Cancer Therapy Evaluation Program).

- Include v4.4
Trial Attribute CTEP ID - Include v4.4
 For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers.

Lead Organization

The

Include Page
Trial Attribute Lead Org Name - Include v4.4

Name of the principal administrative organization responsible for this trial's research protocol.

Trial Attribute Lead Org Name - Include v4.4
For more information, refer to Abstracting Sponsors and Responsible Parties.

SponsorName of the primary organization that oversees implementation of study and is responsible for data analysis.

The

Include Page
Trial Attribute Sponsor - Include v4.4
Trial Attribute Sponsor - Include v4.4
 For more information, refer to Abstracting Sponsors and Responsible Parties.

Send trial information to Clinical Trial Information to ClinicalTrials.gov

A value telling the system

Include Page
Trial Attribute Send to CTgov - Include v4.4
Trial Attribute Send to CTgov - Include v4.4
:

  • Yes. An abstractor has told the system to send

Value indicating whether the system sends the trial information to ClinicalTrials.gov in the automated nightly batch updates (via FTP):

Yes. The system sends
  • the trial information.
  • No.
The system does
  • An abstractor has told the system to not send the trial information.
  • N/A. The trial does not satisfy other criteria.

For more information, refer to Abstracting NCI-Specific Information.

Completion Date

The

Include Page
Trial Attribute Completion Date - Include v4.4

Date on which final data was collected for the trial, or the date on which that is expected to happen.

Trial Attribute Completion Date - Include v4.4
For more information, refer to Abstracting Trial Statuses.

Processing Status

The

Include Page
Trial Attribute Current Trial Processing Status - Include v4.4
Trial Attribute Current Trial Processing Status - Include v4.4
 For

Value indicating the current processing status of the trial. For more

information, refer to

Abstracting

Trial Processing Statuses and Abstracting Trial

Processing

Statuses

in the CTRP.

.

Current Trial Status

The

Include Page
Trial Attribute Current Trial Status - Include v4.4
Trial Attribute Current Trial Status - Include v4.4
 For details, refer to Trial

Current trial statusCurrent stage or state of a clinical trial or study relative to other stages and its ability to enroll participants/patients. For more information, refer to Abstracting Trial Statuses and Trial

Status Values in the CTRP and ClinicalTrials.gov and Abstracting Trial Statuses.

Primary Completion Date

The

Include Page
Trial Attribute Primary Completion Date - Include v4.4

Date on which the final subject was examined or received an intervention, or the date on which that is expected to happen.

Trial Attribute Primary Completion Date - Include v4.4
 For more information, refer to Abstracting Trial Statuses.

Primary Completion TypeValue indicating whether the completion date is the one on which the trial is expected to complete (Anticipated), or the date on which it actually completed (Actual).

A

Include Page
Trial Attribute Primary Completion Date Type - Include v4.4
Trial Attribute Primary Completion Date Type - Include v4.4
 

For more information, refer to Abstracting Trial Statuses.

Section 801 IndicatorValue indicating whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801.

A value indicating 

Include Page
Trial Attribute 801 Indicator - Include v4.4
Trial Attribute 801 Indicator - Include v4.4

For more information, refer to Abstracting Regulatory Information.

Processing Comments

Any

comments that an abstractor has recorded for this trial, on the Trial Identification page or Dashboard Details

Include Page
Trial Attribute Processing Comments - Include v4.4
Trial Attribute Processing Comments - Include v4.4
An abstractor can add comments on the Dashboard Details page or the Trial Identification page. For more information, refer to Tracking and Managing Trial Records or Viewing Trial Identification Details.

CTRO Override Flag CommentsAny comments that an abstractor has recorded (with the "Send Trial Information to ClinicalTrials.gov?" value) for this trial. For more information, refer to Abstracting NCI-Specific Information.

...

hiddentrue
.